Brief: Homology Medicines Reports First Quarter 2023 Financial Results

Q32 Bio

11/05/2023 21:25

May 11 (Reuters) - Homology Medicines Inc  FIXX.O :
    * HOMOLOGY MEDICINES REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND RECENT HIGHLIGHTS
    * HOMOLOGY MEDICINES INC - NET LOSS FOR QUARTER ENDED MARCH
31,
2023 WAS $28.8 MILLION OR $0.50 PER SHARE

Source text for Eikon:  ID:nGNXc1mzPb 
Further company coverage:  FIXX.O 

 ((Reuters.Briefs@thomsonreuters.com;))